Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vincristine-loaded hydroxyapatite nanoparticles as a potential delivery system for bone cancer therapy
Ana Luiza Chaves Maia, Carolina A. Ferreira, André Luís Branco de Barros, et al.
Journal of drug targeting (2017) Vol. 26, Iss. 7, pp. 592-603
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Recent advances in biomedical engineering of nano-hydroxyapatite including dentistry, cancer treatment and bone repair
Mingzu Du, Jingdi Chen, Kaihua Liu, et al.
Composites Part B Engineering (2021) Vol. 215, pp. 108790-108790
Closed Access | Times Cited: 219
Bioinspired adhesive and tumor microenvironment responsive nanoMOFs assembled 3D-printed scaffold for anti-tumor therapy and bone regeneration
Yanan Jiang, Ximan Pan, M. Yao, et al.
Nano Today (2021) Vol. 39, pp. 101182-101182
Closed Access | Times Cited: 114
3D‐Printed Tissue‐Specific Nanospike‐Based Adhesive Materials for Time‐Regulated Synergistic Tumor Therapy and Tissue Regeneration In Vivo
Hyun Lee, Ginam Han, Yuhyun Na, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 48
Closed Access | Times Cited: 22
Recent advances of drug delivery nanocarriers in osteosarcoma treatment
Shang‐Yu Wang, Hong-Zhi Hu, Xiang-Cheng Qing, et al.
Journal of Cancer (2019) Vol. 11, Iss. 1, pp. 69-82
Open Access | Times Cited: 110
Mesenchymal Stem Cell Derived Exosomes as Nanodrug Carrier of Doxorubicin for Targeted Osteosarcoma Therapy via SDF1-CXCR4 Axis
Hongxiang Wei, Fei Chen, Jin-Yuan Chen, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 3483-3495
Open Access | Times Cited: 68
Hydroxyapatite Nanoparticles for Improved Cancer Theranostics
Saeid Kargozar, Sahar Mollazadeh Beidokhti, Farzad Kermani, et al.
Journal of Functional Biomaterials (2022) Vol. 13, Iss. 3, pp. 100-100
Open Access | Times Cited: 61
Vincristine-based nanoformulations: a preclinical and clinical studies overview
Rahul Shukla, Ajit Singh, Kamalinder K. Singh
Drug Delivery and Translational Research (2023) Vol. 14, Iss. 1, pp. 1-16
Open Access | Times Cited: 23
Bone Targeting Nanoparticles for the Treatment of Osteoporosis
Caining Wen, Xiao Xu, Yuanmin Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 1363-1383
Open Access | Times Cited: 11
A 10-year bibliometric analysis in the field of osteosarcoma treatment from 2014 to 2023
Yiguo Shen, Xiao-Bo Shao, Jiansong Chen, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Programmed cell death, redox imbalance, and cancer therapeutics
Xiaofeng Dai, Danjun Wang, Jianying Zhang
APOPTOSIS (2021) Vol. 26, Iss. 7-8, pp. 385-414
Closed Access | Times Cited: 50
Magnetic bioactive glasses/Cisplatin loaded-chitosan (CS)-grafted- poly (ε-caprolactone) nanofibers against bone cancer treatment
Zahra Amini, Sam Shekofte Rudsary, Seyed Sadegh Shahraeini, et al.
Carbohydrate Polymers (2021) Vol. 258, pp. 117680-117680
Closed Access | Times Cited: 44
Recent advances in drug delivery systems for osteosarcoma therapy and bone regeneration
Sally Kortam, Zufu Lu, Hala Zreiqat
Communications Materials (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 6
Syntheses and applications of mesoporous hydroxyapatite: a review
Olaiya Peter Oni, Yan Hu, Sijie Tang, et al.
Materials Chemistry Frontiers (2022) Vol. 7, Iss. 1, pp. 9-43
Closed Access | Times Cited: 27
Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma-an updated review
Sumel Ashique, Md. Faiyazuddin, Obaid Afzal, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104753-104753
Closed Access | Times Cited: 13
Chick embryo chorioallantoic membrane as a suitable in vivo model to evaluate drug delivery systems for cancer treatment: A review
Francesca Damiani Victorelli, Valéria Maria de Oliveira Cardoso, Natália Noronha Ferreira, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2020) Vol. 153, pp. 273-284
Closed Access | Times Cited: 39
Bridging the In Vitro to In Vivo gap: Using the Chick Embryo Model to Accelerate Nanoparticle Validation and Qualification for In Vivo studies
Kimberly S. Butler, C. Jeffrey Brinker, Hon S. Leong
ACS Nano (2022) Vol. 16, Iss. 12, pp. 19626-19650
Open Access | Times Cited: 20
Quantitative Analysis of Salmon Calcitonin Hydroxyapatite Nanoparticle Permeation to substantiate Non-Invasive Bone Targeting via Sublingual Delivery
Darsheen J. Kotak, Esha S. Attar, Bhavik Dalal, et al.
AAPS PharmSciTech (2025) Vol. 26, Iss. 4
Closed Access
Polymeric Composite Soft Materials for Anticancer Drug Delivery and Detection
T. Mohanraj, Thavasilingam Nagendraraj, Jamespandi Annaraj, et al.
(2025), pp. 165-216
Closed Access
The Chorioallantoic Membrane Assay in Nanotoxicological Research—An Alternative for In Vivo Experimentation
Christoph Raphael Buhr, Nadine Wiesmann, Rachel Tanner, et al.
Nanomaterials (2020) Vol. 10, Iss. 12, pp. 2328-2328
Open Access | Times Cited: 31
Hydroxyapatite for Biomedicine and Drug Delivery
Behrad Ghiasi, Yahya Sefidbakht, Maryam Rezaei
Advanced structured materials (2019), pp. 85-120
Closed Access | Times Cited: 27
Nanocarrier-based drug delivery systems for bone cancer therapy: a review
S. Ram Prasad, T. S. Sampath Kumar, A. Jayakrishnan
Biomedical Materials (2021) Vol. 16, Iss. 4, pp. 044107-044107
Closed Access | Times Cited: 21
Progress of biomaterials for bone tumor therapy
Hanzheng Chen, Yongchang Yao
Journal of Biomaterials Applications (2021) Vol. 36, Iss. 6, pp. 945-955
Closed Access | Times Cited: 21
Application of nanoparticles in drug delivery for the treatment of osteosarcoma: focussing on the liposomes
Wenqing Liang, Yongqiang Dong, Ruyi Shao, et al.
Journal of drug targeting (2021) Vol. 30, Iss. 5, pp. 463-475
Closed Access | Times Cited: 18
Hydroxyapatite nanorods loaded with parathyroid hormone (PTH) synergistically enhance the net formative effect of PTH anabolic therapy
Jay R. Dave, Ankush Dewle, Suhas T. Mhaske, et al.
Nanomedicine Nanotechnology Biology and Medicine (2018) Vol. 15, Iss. 1, pp. 218-230
Closed Access | Times Cited: 22
The Janus Nature of Nanohydroxyapatite in Tumor Progression
Jiaying He, Min‐juan Shen, Qianqian Wan, et al.
Advanced Functional Materials (2021) Vol. 32, Iss. 9
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top